Baxter International Inc. $BAX Shares Acquired by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio lifted its position in Baxter International Inc. (NYSE:BAX) by 1.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 159,040 shares of the medical instruments supplier’s stock after acquiring an additional 2,226 shares during the period. Public Employees Retirement System of Ohio’s holdings in Baxter International were worth $4,816,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently made changes to their positions in BAX. Dodge & Cox increased its position in shares of Baxter International by 2.1% in the 1st quarter. Dodge & Cox now owns 51,458,925 shares of the medical instruments supplier’s stock valued at $1,761,439,000 after acquiring an additional 1,081,631 shares during the period. ARGA Investment Management LP boosted its holdings in Baxter International by 52.5% in the first quarter. ARGA Investment Management LP now owns 1,327,946 shares of the medical instruments supplier’s stock valued at $45,456,000 after purchasing an additional 457,345 shares during the last quarter. GAMMA Investing LLC boosted its holdings in Baxter International by 11,821.6% in the first quarter. GAMMA Investing LLC now owns 387,689 shares of the medical instruments supplier’s stock valued at $13,271,000 after purchasing an additional 384,437 shares during the last quarter. Sound Shore Management Inc. CT boosted its holdings in Baxter International by 13.7% in the first quarter. Sound Shore Management Inc. CT now owns 2,825,902 shares of the medical instruments supplier’s stock valued at $96,731,000 after purchasing an additional 341,321 shares during the last quarter. Finally, OVERSEA CHINESE BANKING Corp Ltd purchased a new stake in Baxter International in the first quarter valued at $8,426,000. 90.19% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. Morgan Stanley lowered their price target on shares of Baxter International from $28.00 to $27.00 and set an “underweight” rating on the stock in a report on Tuesday, July 15th. Wells Fargo & Company lowered their price target on shares of Baxter International from $33.00 to $24.00 and set an “equal weight” rating on the stock in a report on Friday, August 1st. The Goldman Sachs Group lowered shares of Baxter International from a “buy” rating to a “neutral” rating and set a $25.00 price target on the stock. in a report on Friday, August 1st. Barclays lowered their price target on shares of Baxter International from $41.00 to $36.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Finally, Stifel Nicolaus reissued a “hold” rating and set a $25.00 target price (down from $36.00) on shares of Baxter International in a research note on Monday, August 4th. Three analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $30.11.

Baxter International Stock Up 1.7%

BAX opened at $22.36 on Tuesday. Baxter International Inc. has a twelve month low of $21.33 and a twelve month high of $38.28. The company has a quick ratio of 1.49, a current ratio of 2.30 and a debt-to-equity ratio of 1.30. The company has a 50-day moving average price of $24.30 and a 200 day moving average price of $28.37. The company has a market cap of $11.48 billion, a PE ratio of -74.52, a price-to-earnings-growth ratio of 0.72 and a beta of 0.61.

Baxter International (NYSE:BAX) last released its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.60 by ($0.01). The company had revenue of $2.81 billion for the quarter, compared to analyst estimates of $2.82 billion. Baxter International had a positive return on equity of 16.96% and a negative net margin of 1.42%.The firm’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same quarter last year, the company earned $0.68 EPS. Baxter International has set its Q3 2025 guidance at 0.580-0.620 EPS. FY 2025 guidance at 2.420-2.520 EPS. Sell-side analysts expect that Baxter International Inc. will post 2.48 earnings per share for the current fiscal year.

Baxter International Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 1st. Shareholders of record on Friday, August 29th will be issued a $0.17 dividend. The ex-dividend date is Friday, August 29th. This represents a $0.68 dividend on an annualized basis and a yield of 3.0%. Baxter International’s dividend payout ratio is presently -226.67%.

Baxter International Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.